Cooley Leads 2 Biotech Firms Pricing IPOs Totaling $496M
Two biotechnology firms began trading publicly Friday after raising a combined $496 million in their initial public offerings, with Cooley LLP advising both companies and Latham & Watkins LLP advising both...To view the full article, register now.
Already a subscriber? Click here to view full article